Literature DB >> 26590836

Psychiatric Comorbidity in Alcohol Dependence.

George Fein1,2,3.   

Abstract

We review our clinical studies of psychiatric comorbidity in short-term and long-term abstinent and in treatment naïve alcoholics (STAA, LTAA and TNA). TNA ypically have less severe alcoholism than treated abstinent samples and evidence less severe psychiatric disturbance. Lifetime psychiatric diagnoses are the norm for STAA and LTAA but not for TNA. Individuals with alcohol and drug use disorders show greater antisocial personality disturbance, but do not show differences in the mood or anxiety domains or in borderline personality disorder (BPD) symptoms. The studies show that alcoholics can achieve and maintain abstinence in the face of ongoing mood, anxiety, or BPD problems. By contrast, for ASPD, LTAA essentially stop current antisocial behaviors in all seven domains of antisocial behaviors. We believe that ongoing antisocial behavior is not consistent with maintaining abstinence, and that LTAA modify their antisocial behavior despite continued elevated social deviance proneness and antisocial dispositionality. Abstinent individuals without lifetime psychiatric disorders and TNA show more (subdiagnostic threshold) psychiatric symptoms and abnormal psychological measures than non-alcoholic controls in the mood, anxiety, BPD, and antisocial domains. In summary, our studies show that although LTAA have achieved multi-year abstinence, they still report significant psychological distress compared to NAC. We believe this distress may negatively affect their quality of life. This suggests the importance of developing effective care models to address comorbid mental health problems in LTAA. We also show that antisocial personality disorder symptoms decline to the levels seen in normal controls, and that excluding individuals from research with a psychiatric diagnosis does not control for subdiagnostic psychiatric differences between alcoholics and controls.

Entities:  

Keywords:  Alcoholism; Psychiatric comorbidity

Mesh:

Year:  2015        PMID: 26590836      PMCID: PMC5021191          DOI: 10.1007/s11065-015-9304-y

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  70 in total

1.  Inhibition errors in borderline personality disorder with psychotic-like symptoms.

Authors:  Koen P Grootens; Gilles van Luijtelaar; Jan K Buitelaar; Annemieke van der Laan; Jacobus W Hummelen; Robbert J Verkes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-24       Impact factor: 5.067

2.  Gender-specific mortality associated with alcohol consumption in Poland in transition.

Authors:  Bogdan Wojtyniak; Jacek Moskalewicz; Jakub Stokwiszewski; Daniel Rabczenko
Journal:  Addiction       Date:  2005-12       Impact factor: 6.526

3.  Comorbidity of major depression with substance use disorders.

Authors:  Shawn R Currie; Scott B Patten; Jeanne V A Williams; JianLi Wang; Cynthia A Beck; Nady El-Guebaly; Colleen Maxwell
Journal:  Can J Psychiatry       Date:  2005-09       Impact factor: 4.356

4.  Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations.

Authors:  Deborah A Dawson; Bridget F Grant; Frederick S Stinson; Patricia S Chou
Journal:  Drug Alcohol Depend       Date:  2005-02-14       Impact factor: 4.492

5.  Sub-diagnostic psychiatric comorbidity in alcoholics.

Authors:  George Fein; Victoria Di Sclafani; Peter Finn; Diane L Scheiner
Journal:  Drug Alcohol Depend       Date:  2006-09-11       Impact factor: 4.492

6.  Axis I comorbidity of borderline personality disorder.

Authors:  M C Zanarini; F R Frankenburg; E D Dubo; A E Sickel; A Trikha; A Levin; V Reynolds
Journal:  Am J Psychiatry       Date:  1998-12       Impact factor: 18.112

7.  Does psychiatric comorbidity in alcohol-dependent patients affect treatment outcome?

Authors:  Karl Mann; Thomas Hintz; Martin Jung
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-06       Impact factor: 5.270

8.  Alcoholic patients with secondary depression.

Authors:  M Schuckit
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

9.  Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study.

Authors:  Dawn M Johnson; M Tracie Shea; Shirley Yen; Cynthia L Battle; Caron Zlotnick; Charles A Sanislow; Carlos M Grilo; Andrew E Skodol; Donna S Bender; Thomas H McGlashan; John G Gunderson; Mary C Zanarini
Journal:  Compr Psychiatry       Date:  2003 Jul-Aug       Impact factor: 3.735

10.  Frontal brain dysfunction in alcoholism with and without antisocial personality disorder.

Authors:  Marlene Oscar-Berman; Mary M Valmas; Kayle S Sawyer; Shalene M Kirkley; David A Gansler; Diane Merritt; Ashley Couture
Journal:  Neuropsychiatr Dis Treat       Date:  2009-06-10       Impact factor: 2.570

View more
  5 in total

1.  Resting state synchrony in long-term abstinent alcoholics: Effects of a current major depressive disorder diagnosis.

Authors:  George Fein; Jazmin Camchong; Valerie A Cardenas; Andy Stenger
Journal:  Alcohol       Date:  2016-11-23       Impact factor: 2.405

2.  Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.

Authors:  Pablo Barrio; Lluisa Ortega; Josep Guardia; Carlos Roncero; Lara Yuguero; Antoni Gual
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

Review 3.  Cognitive training as a component of treatment of alcohol use disorder: A review.

Authors:  Sara Jo Nixon; Ben Lewis
Journal:  Neuropsychology       Date:  2019-09       Impact factor: 3.295

4.  Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study.

Authors:  A Uhlmann; B Bandelow; D J Stein; S Bloch; K R Engel; U Havemann-Reinecke; Dirk Wedekind
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-01-25       Impact factor: 5.270

5.  Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice.

Authors:  Laura B Ferguson; Angela R Ozburn; Igor Ponomarev; Pamela Metten; Matthew Reilly; John C Crabbe; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2017-12-18       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.